Read the latest news from Saama.
Learning Lessons from Abbott’s Global Pandemic Defense Coalition In response to an article in Modern Healthcare on the Abbott Pandemic Defense Coalition, Nekzad Shroff, Saama’s
Overcoming Current Surveillance Challenges With the biggest U.S. vaccine initiative currently underway, research indicates that 39% of Americans are reluctant to get vaccinated. Writing for
Pharma Is Embracing AI to Accelerate Clinical Trials To celebrate Saama’s Smart Application integration with Oracle Health Sciences’ Clinical One Platform, Saama’s chief strategy officer
A Paradigm Shift in Drug Development To celebrate the 20th anniversary of PharmaVOICE, the magazine asked dozens of industry thought leaders to share their views
Smart Data Query “Saved…an Entire Month” As Pfizer scientists raced to develop its COVID-19 vaccine at record-breaking speed, they developed an innovative artificial intelligence (AI)
The Intelligent Clinical Cloud Emerges In a new PharmaVOICE feature tracking the latest trends in life sciences, Saama’s Chief Strategy Officer, Sagar Anisingaraju, makes the
Outsourcing-Pharma Interviews William H. Carson, M.D. Pharma veteran William H. Carson, M.D. has a proven track record of success in R&D, clinical development, and regulatory
Is that COVID or Just a Cough? Newly developed deep learning/AI models that can classify cough sounds as a prescreening tool for COVID-19 show promising
How Machines Are Transforming Life Sciences Artificial intelligence is expected to play an even bigger role in pharma’s future, as long as regulatory concerns, investment
